Levofloxacin, a widely prescribed fluoroquinolone antibiotic, carries a side-effect profile that ranges from mild digestive upset to rare but serious damage affecting tendons, nerves, the heart, and the brain. Most people who take a short course tolerate it without lasting problems, but the drug’s potential for severe reactions prompted the U.S. FDA to add multiple boxed warnings over the years. Understanding which side effects are common, which are rare, and who is most vulnerable can help you have a more informed conversation with your doctor if levofloxacin is on the table.
Common, Everyday Side Effects
The side effects most people experience with levofloxacin are gastrointestinal: nausea, diarrhea, and stomach discomfort. Headache and dizziness round out the list of frequent complaints. A broad safety review found that gastrointestinal and central-nervous-system symptoms, particularly headache and dizziness, are the most commonly reported adverse events across the fluoroquinolone class.1PubMed. Safety profile of the fluoroquinolones: focus on levofloxacin These tend to be mild and resolve once you finish the course. Insomnia and constipation also show up on prescribing labels. While uncomfortable, these routine effects are rarely a reason to stop treatment on their own.
Tendon Damage and Rupture
The most infamous side effect of levofloxacin is tendon injury, especially to the Achilles tendon. Fluoroquinolones disrupt collagen production in tendon cells. The drugs bind to metal ions that serve as building blocks for enzymes responsible for collagen remodeling. When those enzymes cannot do their job properly, tendons weaken from the inside out.2PubMed Central. Fluoroquinolone-Induced Achilles Tendon Damage: Structural and Biochemical Insights into Collagen Type I Alterations Lab studies on tendon cells show that fluoroquinolones reduce collagen stiffness and fibril diameter, along with lowering production of fibronectin, a protein that helps cells anchor to surrounding tissue. The researchers behind that work suggest this loss of cell anchoring could trigger a form of cell death that sets the stage for tendinopathy.
In absolute terms, the risk of a tendon actually rupturing is low for most people. A population-based study calculated an adjusted rate of roughly 2 additional Achilles tendon ruptures per 10,000 patients exposed to fluoroquinolones compared with unexposed patients.3PubMed Central. Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study That number climbs sharply if you are over 60 and taking oral corticosteroids at the same time. In that group, the interaction between the two drugs drove Achilles rupture rates up to roughly 7 per 10,000, and any-tendon rupture rates close to 20 per 10,000.4PubMed Central. Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study If you notice tendon pain, swelling, or a snapping sensation while taking levofloxacin, stopping the drug and contacting your prescriber promptly is the standard advice.
Peripheral Nerve Damage
Levofloxacin can injure peripheral nerves, causing tingling, burning, numbness, or pain in the hands and feet. A large self-controlled case-series study found that current fluoroquinolone use was linked to about a 47% higher rate of peripheral neuropathy compared with periods of non-use, and the risk rose by roughly 3% for each additional day of exposure.5JAMA Neurology. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy That elevated risk persisted for up to six months after stopping the drug.
The onset can be fast. In a review of adverse-event reports, about a third of neuropathy cases began within 24 hours of starting a fluoroquinolone, and more than 80% surfaced within the first week.6PubMed. Peripheral neuropathy associated with fluoroquinolones Recovery is not guaranteed, either. In that same review, symptoms had lasted longer than a year in over half the cases. This is one reason the FDA boxed warning specifically flags peripheral neuropathy as potentially irreversible.
Brain and Psychiatric Effects
Levofloxacin crosses into the brain, where it can interfere with signaling between nerve cells. The drug blocks a calming receptor (GABA-A) while simultaneously activating an excitatory one (NMDA), creating a state of excessive neural firing. When levofloxacin levels run high, this imbalance can produce confusion, seizures, or involuntary jerking movements.7PubMed Central. Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid People with impaired kidney function are at elevated risk because the drug clears more slowly and accumulates to higher concentrations.
Psychiatric reactions are rarer but well documented. Case reports describe acute psychosis appearing in patients ranging from otherwise-healthy young women to older adults with diabetes, sometimes within days of starting levofloxacin.8PubMed Central. Levofloxacin-induced acute psychosis9PubMed Central. Levofloxacin-induced Psychosis in a Young Healthy Patient A pharmacovigilance analysis of the FDA’s adverse-event database found that psychiatric reactions to fluoroquinolones were reported more often in women and in adults between 19 and 64 years old, and most appeared within 10 days of starting the drug. On the encouraging side, roughly two-thirds of those reactions resolved within three days of stopping the antibiotic.10PubMed. Fluoroquinolones-related psychiatric adverse events: a real‑world retrospective and pharmacovigilance database analysis
Heart Rhythm and Vascular Risks
Levofloxacin can lengthen the QT interval on an electrocardiogram, a change that, in extreme cases, sets the stage for dangerous heart rhythms. In a study of cardiac patients being treated for pneumonia, over 80% showed some degree of QT prolongation while on levofloxacin, with an average increase of about 16 milliseconds.11PubMed. Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia That study focused on people already dealing with heart disease, so the findings don’t translate directly to healthy adults. But the risk increases whenever levofloxacin is combined with other drugs that also prolong the QT interval, such as certain antidepressants and antipsychotics.12PubMed. QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine Compared to moxifloxacin, another fluoroquinolone, levofloxacin is considered a weaker blocker of the cardiac ion channel responsible for QT changes.13Journal of Korean Society of Health-System Pharmacists. Incidence and Risk Factors for QT Prolongation associated with Fluoroquinolones
A separate vascular concern is aortic aneurysm and dissection. A meta-analysis of four studies found that current fluoroquinolone users had roughly double the risk of developing an aortic aneurysm or dissection compared with non-users.14PubMed Central. Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis A large U.S. study using Veterans Affairs data echoed this, finding that fluoroquinolone prescriptions were associated with higher 90-day rates of abdominal aortic aneurysm and a nearly doubled rate of aneurysm repair compared to other antibiotics.15JAMA Surgery. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm The absolute risk remains small for most people, but if you already have a known aortic condition or are at elevated cardiovascular risk, this is worth discussing with your doctor.
Liver Injury
Drug-induced liver damage from levofloxacin is rare but can be serious. The exact mechanism is not well understood. Published case reports describe patients developing signs of hepatitis, with liver enzymes climbing rapidly after starting levofloxacin, sometimes progressing to severe or even fatal liver failure.16PubMed Central. Hepatotoxicity Secondary to Levofloxacin Use People with pre-existing liver damage may be more susceptible. Current guidance calls for stopping levofloxacin immediately if signs of hepatitis appear or if liver enzyme levels begin rising rapidly during treatment.17American Journal of Case Reports. A Case of Levofloxacin-Induced Hepatotoxicity
Kidney Injury
Levofloxacin is eliminated primarily through the kidneys, and in uncommon instances it can cause kidney damage through two pathways. One is crystal nephropathy, where the drug crystallizes inside the kidney’s tubules and physically obstructs them. Only a handful of cases have been reported in the literature.18PubMed Central. A Rare Case of Acute Kidney Injury Due to Levofloxacin-induced Crystal Nephropathy Staying well hydrated during treatment is a simple way to lower that risk. The other pathway is an immune-mediated reaction called acute interstitial nephritis, in which the immune system attacks kidney tissue in response to the drug. In one documented case, a 75-year-old woman developed acute kidney injury after levofloxacin treatment, confirmed by kidney biopsy, and improved after being given corticosteroids.19Gazzetta Medica Italiana Archivio per le Scienze Mediche. Levofloxacin-induced acute interstitial nephritis Both forms are rare but worth knowing about, especially if you already have reduced kidney function.
Skin Reactions and Sun Sensitivity
Skin reactions are among the more visible side effects of levofloxacin, though they are usually mild. An analysis of cutaneous adverse events found that about 89% were minor, with rashes, itching, and hives accounting for the majority of cases.20PubMed Central. Levofloxacin-Induced Cutaneous Adverse Reactions: Characteristics and Rational Use Strategies Severe skin reactions like exfoliative dermatitis were very uncommon in that dataset.
As for sun sensitivity, levofloxacin actually performs quite well compared to some of its fluoroquinolone cousins. In a randomized controlled trial comparing the phototoxic potential of several fluoroquinolones against placebo, levofloxacin produced no detectable phototoxic reaction, performing on par with the placebo group.21British Journal of Dermatology. A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity Another trial in healthy volunteers similarly found no significant difference in skin reactions between levofloxacin-treated subjects and placebo recipients after UV exposure.22PubMed. Photoreaction potential of orally administered levofloxacin in healthy subjects That does not mean you can skip sunscreen entirely while taking the drug, but levofloxacin is not in the same league as sparfloxacin or enoxacin when it comes to making your skin burn.
Who Faces the Highest Risk
Certain groups are substantially more vulnerable to levofloxacin’s serious side effects. The biggest risk factors for tendon rupture are age over 60, concurrent use of oral corticosteroids, and kidney transplant.23PubMed. Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration’s adverse event reporting system The combination of a fluoroquinolone with a corticosteroid in someone over 60 is a particularly dangerous cocktail for tendons, with one study finding a roughly 19-fold increase in the incidence rate of Achilles tendon rupture compared with people exposed to neither drug.24PubMed Central. Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study
Impaired kidney function is another cross-cutting risk factor. Because levofloxacin is cleared by the kidneys, slower clearance means higher drug levels in the blood and cerebrospinal fluid, which amplifies neurotoxic and cardiotoxic effects. People with diabetes face additional concerns because fluoroquinolones can disrupt blood sugar in both directions. Pre-existing heart conditions or use of other QT-prolonging medications also raise the stakes for cardiac side effects. None of this means levofloxacin is off-limits for these groups, but it does mean the prescribing decision should weigh the severity of the infection against the elevated risk, and alternatives should be considered when they exist.
The Mitochondrial Connection
Many of levofloxacin’s seemingly unrelated side effects share a common thread at the cellular level: mitochondrial damage. Levofloxacin interferes with the mitochondrial electron transport chain, the machinery that cells use to produce energy. Whole-proteome analyses of human cells treated with levofloxacin and ciprofloxacin revealed prominent dysfunction in complexes I and IV of that chain, along with disruption of two specific mitochondrial proteins, AIFM1 and IDH2.25PubMed Central. Chemical Proteomics Reveals Human Off-Targets of Fluoroquinolone Induced Mitochondrial Toxicity When the cell’s energy production falters, it produces a surge of reactive oxygen species, essentially molecular shrapnel that damages proteins, membranes, and DNA. Lab research on lung cancer cells confirmed that levofloxacin drives up levels of these destructive molecules and that antioxidants like vitamin C can partially counteract the effect.26PubMed. Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage
This mitochondrial toxicity helps explain why the drug can hurt so many different tissues. Tendons, nerves, heart muscle, and retinal cells all depend heavily on mitochondrial energy output. When fluoroquinolones hobble that output and simultaneously flood the cell with oxidative stress, tissues with high energy demands are the first to suffer. It also offers a clue as to why some people are hit much harder than others: individual differences in mitochondrial health and genetic variations in drug metabolism could determine how much damage accumulates before the body can clear the drug.
Fluoroquinolone-Associated Disability
Some people experience a cluster of symptoms that persist for months or even years after finishing a fluoroquinolone course. This condition is increasingly referred to as fluoroquinolone-associated disability, or FQAD. Patients report fatigue, difficulty concentrating, widespread pain in tendons and joints, and nerve-related symptoms long after the antibiotic has left their system.27PubMed Central. Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications The condition is still poorly understood and can be difficult to diagnose because standard lab work often comes back normal.
Animal research is beginning to fill in some gaps. A rodent model using ciprofloxacin found that even low doses caused a transient anxiety-like behavior that resolved within a few weeks, but also produced accelerated gut motility that persisted well after the drug was discontinued.28PubMed Central. Fluoroquinolone-Associated Disability: A Rodent Model Reveals Transient Neuropsychiatric and Persistent Gastrointestinal Effects of Low-Dose Ciprofloxacin That finding is noteworthy because gastrointestinal dysfunction is frequently reported by FQAD patients but is not yet formally recognized as part of the syndrome. The mitochondrial and oxidative-stress pathways described earlier are thought to underlie much of FQAD, and treatments under investigation focus on supporting mitochondrial recovery and reducing oxidative damage.
How Levofloxacin Compares Within Its Class
Fluoroquinolones are not all the same when it comes to safety. Several members of the class have been pulled from the market entirely because of toxicity: trovafloxacin for liver failure, grepafloxacin for fatal cardiac arrhythmias, and temafloxacin for hemolytic anemia, among others. Levofloxacin has survived this culling, and comparative reviews generally rate it as relatively well tolerated within the class, with lower rates of clinically significant cardiac toxicity, central-nervous-system toxicity, and blood-sugar disruption than some of its relatives.29PubMed. Safety profile of the fluoroquinolones: focus on levofloxacin30Current Therapeutic Research. Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review
“Relatively well tolerated” is not the same as safe, though. The FDA and European Medicines Agency have concluded that the serious risks, including neuropsychiatric toxicity, long-term disability, and aortic damage, apply to the entire fluoroquinolone class.31PubMed Central. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency The agency boxed warnings that began appearing in 2008 did eventually lead to modest declines in fluoroquinolone prescribing, though the effect was uneven, with primary care physicians reducing prescriptions more than specialists.32JAMA Network Open. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
The Retinal Detachment Question
An early study raised alarm by finding that current fluoroquinolone use was associated with a roughly 4.5-fold higher risk of retinal detachment, with the average time from first prescription to the event being under five days.33JAMA. Oral Fluoroquinolones and the Risk of Retinal Detachment That finding got a lot of attention, but subsequent research has muddied the picture. A more recent multi-database study comparing fluoroquinolone users with cephalosporin users found no statistically significant increase in the risk of retinal detachment or uveitis.34JAMA Ophthalmology. Systemic Fluoroquinolone Use and Risk of Uveitis or Retinal Detachment The discrepancy may come down to how each study selected its comparison group and controlled for confounders. For now, retinal detachment remains a theoretical concern rather than a confirmed side effect, but people who notice sudden floaters, light flashes, or a shadow in their vision while on any fluoroquinolone should seek prompt eye evaluation regardless of what the statistics say.
Blood Sugar Disruption
Fluoroquinolones have a documented ability to push blood sugar levels in both directions, and levofloxacin is no exception. Animal research showed that at moderate doses, levofloxacin lowered blood sugar and stimulated insulin release, while at higher doses it caused a surge in epinephrine and histamine that drove blood sugar up instead. The fact that an antihistamine blocked the high-dose hyperglycemia suggests histamine release is part of the mechanism. People with diabetes who take levofloxacin need closer blood sugar monitoring because the drug may amplify the effect of their existing glucose-lowering medications or cause unpredictable swings. The prescribing label carries a warning about dysglycemia for this reason, and cases of both severe hypoglycemia and hyperglycemia have been reported in clinical use.
Practical Considerations When Taking Levofloxacin
If you have been prescribed levofloxacin, a few practical steps can help you watch for trouble. Drink plenty of water throughout the course to reduce the already-small risk of kidney crystal formation. Avoid stacking the drug with other medications known to prolong the QT interval unless your doctor has weighed the combination specifically. Let your prescriber know if you are also taking corticosteroids, which multiply the tendon risk. Pay attention to your body during treatment: tendon pain, unusual tingling in the hands or feet, sudden mood changes, or a racing heartbeat all warrant a prompt call. Most serious reactions appear early in the course, often within the first week, so that window deserves extra vigilance.
It is also worth keeping in mind that levofloxacin is reserved for infections where simpler antibiotics won’t do the job. Current FDA guidance says fluoroquinolones should not be first-line treatment for uncomplicated urinary tract infections, sinusitis, or bronchitis when other options are available. If a doctor prescribes levofloxacin for a mild infection without explaining why alternatives were ruled out, that is a reasonable question to ask.